For this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Kristen Fortney, founder and CEO of BioAge Labs. Kristen leads one of just a few companies focused explicitly on aging itself, rather than just the diseases for which aging puts people at greater risk.
We break down each steps involved in a immunostaining (immunohistochemistry or immunofluorescence) experiment and discuss the principles and factors to consider for quality results.
For this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Sam Cooper, cofounder and CEO of Phenomic AI. Sam and his team use machine learning for automated image analysis to study cell biology and screen drugs. But that’s just the beginning.
For this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Shai Shen-Orr, chief scientist of CytoReason, about systems immunology, its potential in medicine, and how CytoReason applies artificial intelligence to make sense of the growing body of immune-related data.
For this episode of the Artificial Intelligence in Drug Discovery podcast, I spoke with Leila Pirhaji of ReviveMed about metabolomics for diagnosis and treatment, and how ReviveMed is using AI to realize its potential.
We discuss the pros and cons of the top 3 commonly used mammalian model organisms in biomedical research.
Dr. David Rimm, Professor at Yale University, shares his perspectives on the challenges of finding antibodies, and how BenchSci has helped.
Much of neuroscience research efforts has been devoted to Alzheimer’s Disease. Here we summarize what is currently known about the biomarkers for Alzheimer’s.
For this episode of the Artificial Intelligence in Drug Discovery podcast, I spoke with Mostapha Benhenda of Startcrowd about a controversial article critiquing several research labs and how the field evolved since he wrote it.
We completed our biggest data run to date! Our antibody search platform has doubled in published antibody use cases and added many more features. Read on to find out what they are.